Skip to main content

Table 1 Patients characteristics and postoperative outcomes in pre- subgroup treatment

From: Efficacy of sivelestat in alleviating postoperative pulmonary injury in patients with acute aortic dissection undergoing total arch replacement: a retrospective cohort study

Variables

Sivelestat (N = 95)

Control (n = 92)

P value

Basic characteristics

Ā Ā 

Age (year)

52.47 ± 11.4

50.99 ± 11.3

0.37

Gender (n, %)#

68, 71.58%

65, 70.65%

0.89

BMI (kg/m²)

24.89 ± 3.35

25.42 ± 3.89

0.33

LVEF (%)

53.62 ± 7.48

53.28 ± 7.31

0.67

Disease history (n, %)

Ā Ā 

Diabetes

6, 5.26%

5, 5.43%

0.79

Hypertension

62, 65.26%

69, 75.00%

0.18

CKD

14, 14.74%

23, 25.00%

0.08

CLD

7, 7.37%

6, 6.52%

0.82

TCO

Ā Ā 

CPB (min)

201.00 (172.00,240.00)

212.50 (186.50,245.75)

0.17

OT(min)

423.08 ± 105.71

418.93 ± 86.75

0.77

CAT (ā„ƒ)

26.10 (25.50,26.90)

26.100 (25.60,26.70)

0.49

Primary outcomes (n, %)

Ā Ā 

30-day mortality

22, 23.16%

17, 18.48%

0.43

ECMO use

3, 3.16%

4, 4.35%

0.67

IABP use

0

0

——

CRRT use

17, 17.89%

19, 20.65%

0.63

Secondary outcomes (n, %)

Ā Ā 

Pneumonia

3, 3.15%

2, 2.17%

1.00

High arterial lactic > 48Ā h

58, 61.05%

48, 52.17%

0.53

Length of ICU stay (days)

4.00 (3.00, 7.00)

4.00 (3.00, 6.75)

0.84

MV time (hours)

22.00 (15.00, 60.00)

19.00 (14.00, 54.00)

0.48

SMV

23, 24.21%

18, 19.57%

0.44

Postoperative thoracic drainage (ml)

1215.00 (953.75, 1675.00)

1225.00 (835.00, 1920.00)

0.96

Length of stay (d)

14.00 (11.00, 18.00)

12.00 (11.00, 18.75)

0.34

  1. #male
  2. BMI, Body mass index; LVEF, Left ventricular ejection fraction; CKD, Chronic kidney disease; CLD, Chronic pulmonary disease; CPB, Cardiopulmonary bypass; OT, operating time; CAT, circulatory arrest temperature. MV, Mechanical ventilation; CRRT, Continuous renal replacement therapy; SMV, secondary mechanical ventilation; ECMO, Extracorporeal membrane oxygenation; IABP, Intra-aortic ballon pump; High arterial lactic, arterial lactic > 2 mmol/L
  3. *P<0.05